DeVore Susan D. 4

What Happened Susan D. DeVore, a director of Solventum Corp (SOLV), was awarded 3,300 restricted stock units (RSUs) on May 15, 2026. The grant is reported as a derivative acquisition at $0.00 per unit (total cash paid $0). Each RSU represents a contingent right to receive one share of common stock upon settlement.

Key Details

• Transaction date: 2026-05-15; Form 4 filed: 2026-05-18 (filed within the SEC’s reporting window).
• Security: 3,300 RSUs (derivative award); reported price: $0.00.
• Shares owned after transaction: not specified in the summary provided.
• Footnotes: F1 — each RSU converts to 1 common share upon settlement; F2 — the RSUs fully vest on May 15, 2027, subject to continued service through that date.
• Transaction code: A (award/grant).

Context RSU grants are typically a form of compensation or retention for insiders and do not reflect an open-market purchase or sale. These units only convert to actual shares if vesting conditions are met (here, continued service through May 15, 2027). As a grant (not a purchase or sale), this transaction is informational about compensation but not a direct market trade signal.